Evaluation of microalbuminuria as a prognostic indicator after a TIA or minor stroke in an outpatient setting: the prognostic role of microalbuminuria in TIA evolution (ProMOTE) study.

William David StrainSalim ElyasNicola WedgeLuke Timothy Allan MounceWilliam HenleyMartin JamesAngela C Shore

Published in: BMJ open (2021)

A risk score comprising age, previous stroke/TIA and microalbuminuria predicts future MACE while identifying those at low risk of a recurrent event. This tool shows promise in the risk stratification of patients to avoid the admission of low-risk patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
emergency department
machine learning
current status
artificial intelligence